Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Euan MacIntyre

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2005
Contribution of the tetrodotoxin-resistant voltage-gated sodium channel NaV1.9 to sensory transmission and nociceptive behaviorBirgit T Priest, Beth A Murphy, Jill A Lindia, et al.
Anesthesiology|September 10, 2015
Identification and Characterization of GAL-021 as a Novel Breathing Control ModulatorFrancis J Golder, Scott Dax, Santhosh M Baby, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Bicyclic amidine inhibitors of nitric oxide synthase: discovery of perhydro-iminopyrindine and perhydro-iminoquinoline as potent, orally active inhibitors of inducible nitric oxide synthaseRavindra N Guthikonda, Shrenik K Shah, Stephen G Pacholok, et al.
Peptides|July 5, 2005
Structure-activity relationship of linear tetrapeptides Tic-DPhe-Arg-Trp-NH2 at the human melanocortin-4 receptor and effects on feeding behaviors in ratZhixiong Ye, Tanya MacNeil, David H Weinberg, et al.
European Journal of Pharmacology|September 5, 2003
Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in ratsLauren P Shearman, Ramon E Camacho, D Sloan Stribling, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2009
Pyridopyrimidine based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluationJohn S Debenham, Christina B Madsen-Duggan, Junying Wang, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2008
3-Amino-1,5-benzodiazepinones: potent, state-dependent sodium channel blockers with anti-epileptic activityScott B Hoyt, Clare London, Matthew J Wyvratt, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2006
Cyclopentane-based human NK1 antagonists. Part 2: development of potent, orally active, water-soluble derivativesLaura C Meurer, Paul E Finke, Karen A Owens, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic painScott B Hoyt, Clare London, David Gorin, et al.
Bioorganic & Medicinal Chemistry Letters|January 8, 2011
1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemiaSampath-Kumar Anandan, Heather Kay Webb, Dawn Chen, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2005
Contribution of the tetrodotoxin-resistant voltage-gated sodium channel NaV1.9 to sensory transmission and nociceptive behaviorBirgit T Priest, Beth A Murphy, Jill A Lindia, et al.
Anesthesiology|September 10, 2015
Identification and Characterization of GAL-021 as a Novel Breathing Control ModulatorFrancis J Golder, Scott Dax, Santhosh M Baby, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Bicyclic amidine inhibitors of nitric oxide synthase: discovery of perhydro-iminopyrindine and perhydro-iminoquinoline as potent, orally active inhibitors of inducible nitric oxide synthaseRavindra N Guthikonda, Shrenik K Shah, Stephen G Pacholok, et al.
Peptides|July 5, 2005
Structure-activity relationship of linear tetrapeptides Tic-DPhe-Arg-Trp-NH2 at the human melanocortin-4 receptor and effects on feeding behaviors in ratZhixiong Ye, Tanya MacNeil, David H Weinberg, et al.
European Journal of Pharmacology|September 5, 2003
Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in ratsLauren P Shearman, Ramon E Camacho, D Sloan Stribling, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2009
Pyridopyrimidine based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluationJohn S Debenham, Christina B Madsen-Duggan, Junying Wang, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2008
3-Amino-1,5-benzodiazepinones: potent, state-dependent sodium channel blockers with anti-epileptic activityScott B Hoyt, Clare London, Matthew J Wyvratt, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2006
Cyclopentane-based human NK1 antagonists. Part 2: development of potent, orally active, water-soluble derivativesLaura C Meurer, Paul E Finke, Karen A Owens, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic painScott B Hoyt, Clare London, David Gorin, et al.
Bioorganic & Medicinal Chemistry Letters|January 8, 2011
1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemiaSampath-Kumar Anandan, Heather Kay Webb, Dawn Chen, et al.
Pageof 4